Literature DB >> 17010508

Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma.

Mercedes Marín-Aguilera1, Lourdes Mengual, María José Ribal, Mireia Musquera, Elisabet Ars, Humberto Villavicencio, Ferran Algaba, Antonio Alcaraz.   

Abstract

OBJECTIVES: To assess the clinical utility of a fluorescence in situ hybridization (FISH) assay as a non-invasive method for diagnosing and monitoring urothelial carcinoma (UC) in the upper urinary tract (UUT).
METHODS: Urine specimens from 30 consecutive patients with UUT UC and 19 healthy controls were analyzed by means of cytology and FISH. For FISH analysis, labelled probes to chromosomes 3, 7, 9, and 17 were used to assess chromosomal abnormalities indicative of malignancy. Sensitivity and specificity of both techniques were determined and compared. The frequency of chromosomal aberrations of malignant cells from UUT was also determined.
RESULTS: Overall sensitivity for FISH was significantly higher than the corresponding value for urine cytology (76.7% vs. 36%, respectively, p=0.0056). Specificities for FISH and cytology were 94.7% and 100%, respectively (p=ns). The positive and negative predictive values for FISH were 95.8% and 72%, whereas for cytology they were 100% and 54%, respectively. Of the genetically altered nuclei counted, 67%, 54%, and 43% presented polysomy in chromosomes 3, 7, and 17, respectively, and 21% presented a homozygous deletion of chromosome 9.
CONCLUSIONS: FISH assay of chromosomes 3, 7, 9, and 17 performed on exfoliated cells from voided urine specimens has greater sensitivity than cytology for detecting UUT UC whilst maintaining a similar specificity. The non-invasive nature of this method and its higher sensitivity could contribute to improving the current diagnosis of UUT UC.

Entities:  

Mesh:

Year:  2006        PMID: 17010508     DOI: 10.1016/j.eururo.2006.08.045

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  20 in total

1.  Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years?

Authors:  Mesut Remzi; Shahrokh Shariat; Wilhelm Huebner; Harun Fajkovic; Christian Seitz
Journal:  Ther Adv Urol       Date:  2011-04

2.  Prospective evaluation of fluorescence in situ hybridization for diagnosing urothelial carcinoma.

Authors:  Tianhai Lin; Zhenhua Liu; Liangren Liu; Lu Yang; Ping Han; Peng Zhang; Qiang Wei
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

Review 3.  Ureteroscopic laser treatment of upper urinary tract neoplasms.

Authors:  Demetrius H Bagley; Michael Grasso
Journal:  World J Urol       Date:  2010-03-14       Impact factor: 4.226

4.  The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer.

Authors:  Mario I Fernández; Sahil Parikh; H Barton Grossman; Ruth Katz; Surena F Matin; Colin P N Dinney; Ashish M Kamat
Journal:  Urol Oncol       Date:  2011-03-10       Impact factor: 3.498

5.  Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis.

Authors:  Amir Hossein Aalami; Farnoosh Aalami
Journal:  Int J Clin Oncol       Date:  2022-07-18       Impact factor: 3.850

6.  Prospective evaluation of FISH for detecting upper tract urothelial carcinoma in voided urine specimens.

Authors:  Qiubo Yu; Yanan Li; Gang Li; Tinghong Li; Han Zeng; Zhu Yang; Deling Wang
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

Review 7.  Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinoma.

Authors:  Victor M Schuettfort; Benjamin Pradere; Fahad Quhal; Hadi Mostafaei; Ekaterina Laukhtina; Keiichiro Mori; Reza Sari Motlagh; Michael Rink; David D'Andrea; Mohammad Abufaraj; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Turk J Urol       Date:  2020-10-09

8.  SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer.

Authors:  Changhao Chen; Hanhao Zheng; Yuming Luo; Yao Kong; Mingjie An; Yuting Li; Wang He; Bowen Gao; Yue Zhao; Hao Huang; Jian Huang; Tianxin Lin
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

Review 9.  UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives.

Authors:  Takashi Nagai; Taku Naiki; Toshiki Etani; Keitaro Iida; Yusuke Noda; Nobuhiko Shimizu; Teruki Isobe; Satoshi Nozaki; Takehiko Okamura; Ryosuke Ando; Noriyasu Kawai; Takahiro Yasui
Journal:  Transl Androl Urol       Date:  2021-04

10.  Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand.

Authors:  Xing-You Jia; Qi Yu; Zhe-Hui Zhang; Xiao-Feng Yang
Journal:  Onco Targets Ther       Date:  2012-05-07       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.